Rezultati - Anton Pozniak

Refine Results
  1. 1
    HIV Drug Resistance — An Emerging Threat to Epidemic Control

    HIV Drug Resistance — An Emerging Threat to Epidemic Control od Chris Beyrer, Anton Pozniak

    Izdano 2017
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Large disparities in HIV treatment cascades between eight European and high‐income countries – analysis of break points

    Large disparities in HIV treatment cascades between eight European and high‐income countries – analysis of break points od Alice Raymond, Andrew Hill, Anton Pozniak

    Izdano 2014
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs

    Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs od Mariana S. Sousa, Anton Pozniak, Marta Boffito

    Izdano 2008
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Are new antiretroviral treatments increasing the risks of clinical obesity?

    Are new antiretroviral treatments increasing the risks of clinical obesity? od Andrew Hill, Laura Waters, Anton Pozniak

    Izdano 2019
    Polni tekst
    Editorial
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Has the time come to abandon efavirenz for first-line antiretroviral therapy?

    Has the time come to abandon efavirenz for first-line antiretroviral therapy? od François Raffi, Anton Pozniak, M A Wainberg

    Izdano 2014
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    The treatment of tuberculosis in HIV-infected persons

    The treatment of tuberculosis in HIV-infected persons od Anton Pozniak, Robert F. Miller, Peter L. Ormerod

    Izdano 1999
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?

    Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety? od Andrew Hill, Sophie Hughes, Dzintars Gotham, Anton Pozniak

    Izdano 2018
    Editorial
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?

    Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety? od Andrew Hill, Sophie Hughes, Dzintars Gotham, Anton Pozniak

    Izdano 2018
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Bacterial Vaginosis, Ethnicity, and the Use of Genital Cleaning Agents: A Case Control Study

    Bacterial Vaginosis, Ethnicity, and the Use of Genital Cleaning Agents: A Case Control Study od Sasikala Rajamanoharan, Nicola Low, Simon B. Jones, Anton Pozniak

    Izdano 1999
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    Rapidly declining HIV infection in MSM in central London

    Rapidly declining HIV infection in MSM in central London od Nneka Nwokolo, Andrew Hill, Alan McOwan, Anton Pozniak

    Izdano 2017
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Gonorrhoea in inner London: results of a cross sectional study

    Gonorrhoea in inner London: results of a cross sectional study od Nicola Low, Gavin Daker‐White, David H. Barlow, Anton Pozniak

    Izdano 1997
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Episodic Sexual Transmission of HIV Revealed by Molecular Phylodynamics

    Episodic Sexual Transmission of HIV Revealed by Molecular Phylodynamics od Fraser Lewis, G. Hughes, Andrew Rambaut, Anton Pozniak, Andrew Brown

    Izdano 2008
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP

    How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP od Victoria Pilkington, Andrew Hill, Sophie Hughes, Nneka Nwokolo, Anton Pozniak

    Izdano 2018
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Does tuberculosis accelerate the progression of HIV disease? Evidence from basic science and epidemiology

    Does tuberculosis accelerate the progression of HIV disease? Evidence from basic science and epidemiology od Julia del Amo, Adam S. Malin, Anton Pozniak, Kevin M. De Cock

    Izdano 1999
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    Clinical management of tuberculosis and HIV-1 co-infection

    Clinical management of tuberculosis and HIV-1 co-infection od Charlotte Schutz, Graeme Meintjes, Fahad Almajid, Robert J. Wilkinson, Anton Pozniak

    Izdano 2010
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    Virologic Rebound on HAART in the Context of Low Treatment Adherence Is Associated With a Low Prevalence of Antiretroviral Drug Resistance

    Virologic Rebound on HAART in the Context of Low Treatment Adherence Is Associated With a Low Prevalence of Antiretroviral Drug Resistance od John Walsh, Anton Pozniak, Mark Nelson, Sundhiya Mandalia, Brian George Gazzard

    Izdano 2002
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    Clinical Characteristics of Iris Syndrome in Patients with HIV and Tuberculosis

    Clinical Characteristics of Iris Syndrome in Patients with HIV and Tuberculosis od Christos Michailidis, Anton Pozniak, Sundhiya Mandalia, Sheena Basnayake, Mark Nelson, Brian Gazzard

    Izdano 2005
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades

    Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades od Jacob Levi, Alice Raymond, Anton Pozniak, Pietro Vernazza, Philipp Köhler, Andrew Hill

    Izdano 2016
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    Comparative Safety and Neuropsychiatric Adverse Events Associated With Efavirenz Use in First-Line Antiretroviral Therapy

    Comparative Safety and Neuropsychiatric Adverse Events Associated With Efavirenz Use in First-Line Antiretroviral Therapy od Nathan Ford, Zara Shubber, Anton Pozniak, Marco Vitória, Meg Doherty, Catherine Kirby, Alexandra Calmy

    Izdano 2015
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Loss of blood CD11c+ myeloid and CD11c−plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load

    Loss of blood CD11c+ myeloid and CD11c−plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load od Heather Donaghy, Anton Pozniak, Brian Gazzard, Nad A. Qazi, Jill Gilmour, Frances Gotch, Steven Patterson

    Izdano 2001
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: